Because of this overproduction of IL-1, a specific treatment of CAPS using anti- IL-1 β monoclonal antibodies such as canakinumab which is a human anti- interleukin-1 β monoclonal antibody are used [4]. Here, IL1B is linked to cryopyrin-associated periodic syndrome.